Altrenogest
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11372 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | orofacial clefting syndrome | KG + DL |
| 2 | interventricular septum aneurysm | KG + DL |
| 3 | Jeune syndrome situs inversus | KG + DL |
| 4 | Pierre Robin syndrome associated with a chromosomal anomaly | KG + DL |
| 5 | genetic syndromic Pierre Robin syndrome | KG + DL |
| 6 | Laubry-Pezzi syndrome | KG + DL |
| 7 | disorder of fucoglycosan synthesis | KG + DL |
| 8 | partial deletion of the long arm of chromosome 7 | KG + DL |
| 9 | partial deletion of the long arm of chromosome 22 | KG + DL |
| 10 | pulmonary valve disease | KG + DL |
| 11 | hemoglobinopathy | KG + DL |
| 12 | heart disease | KG + DL |
| 13 | mitral valve disease | KG + DL |
| 14 | partial deletion of the short arm of chromosome 16 | KG + DL |
| 15 | myocardial infarction | KG + DL |
| 16 | beta-thalassemia with other manifestations | KG + DL |
| 17 | hemolytic anemia due to glucophosphate isomerase deficiency | KG + DL |
| 18 | postoperative ventricular dysfunction | KG + DL |
| 19 | pyruvate kinase deficiency of red cells | KG + DL |
| 20 | posteroinferior myocardial infarction | KG + DL |
| 21 | posterolateral myocardial infarction | KG + DL |
| 22 | pyropoikilocytosis, hereditary | KG + DL |
| 23 | septal myocardial infarction | KG + DL |
| 24 | epiglottitis | KG + DL |
| 25 | coronary thrombosis | KG + DL |
| 26 | tendinitis | KG + DL |
| 27 | heart valve disease | KG + DL |
| 28 | coronary stenosis | KG + DL |
| 29 | myositis fibrosa | KG + DL |
| 30 | idiopathic granulomatous myositis | KG + DL |
| 31 | antithrombin deficiency type 2 | KG + DL |
| 32 | myocardial disorder | KG + DL |
| 33 | heparin cofactor 2 deficiency | KG + DL |
| 34 | factor 5 excess with spontaneous thrombosis | KG + DL |
| 35 | heart neoplasm | KG + DL |
| 36 | heart conduction disease | KG + DL |
| 37 | malignant pleural mesothelioma | KG + DL |
| 38 | congenital anomaly of ventricular septum | KG + DL |
| 39 | laryngitis | KG + DL |
| 40 | pericardium disease | KG + DL |
| 41 | bronchitis | KG + DL |
| 42 | patent ductus arteriosus-bicuspid aortic valve-hand anomalies syndrome | KG + DL |
| 43 | fibromyalgia | KG + DL |
| 44 | congenital coronary artery anomaly | KG + DL |
| 45 | myocardial infarction (disease) | KG + DL |
| 46 | thrombophilia | KG + DL |
| 47 | gout | KG + DL |
| 48 | rheumatoid arthritis | KG + DL |
| 49 | white forelock with malformations | KG + DL |
| 50 | cardiac anomalies-heterotaxy syndrome | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.